XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue Revenue Recognition and Deferred Revenue (Tables)
 3 Months Ended
Mar. 31, 2022
Revenue Recognition and Deferred Revenue [Abstract]  
Revenue from External Customers by Geographic Areas
The following tables present our revenue disaggregated by geographic area, species, and major product category:
Revenue by geographic area
Three Months Ended
March 31,
(MILLIONS OF DOLLARS)20222021
United States$1,020 $933 
Australia65 57 
Brazil77 74 
Canada49 46 
Chile41 34 
China103 123 
France32 35 
Germany43 38 
Italy30 25 
Japan59 47 
Mexico35 33 
Spain33 31 
United Kingdom64 69 
Other developed markets115 111 
Other emerging markets202 199 
1,968 1,855 
Contract manufacturing & human health18 16 
Total Revenue$1,986 $1,871 
Revenue from External Customers by Major Species Revenue by major species
Three Months Ended
March 31,
(MILLIONS OF DOLLARS)20222021
U.S.
Companion animal$774 $658 
Livestock246 275 
1,020 933 
International
Companion animal489 418 
Livestock459 504 
948 922 
Total
Companion animal1,263 1,076 
Livestock705 779 
Contract manufacturing & human health18 16 
Total Revenue$1,986 $1,871 
Revenue from External Customers by Species Revenue by species
Three Months Ended
March 31,
(MILLIONS OF DOLLARS)20222021
Companion Animal:
Dogs and Cats$1,199 $1,016 
Horses64 60 
1,263 1,076 
Livestock:
Cattle364 399 
Swine154 190 
Poultry124 131 
Fish44 37 
Sheep and other19 22 
705 779 
Contract manufacturing & human health18 16 
Total Revenue$1,986 $1,871 
Schedule of Significant Product Revenues Revenue by major product category
Three Months Ended
March 31,
(MILLIONS OF DOLLARS)20222021
Parasiticides$459 $390 
Vaccines405 413 
Dermatology311 248 
Anti-infectives285 321 
Other pharmaceuticals254 226 
Medicated feed additives98 112 
Animal health diagnostics98 89 
Other non-pharmaceuticals58 56 
1,968 1,855 
Contract manufacturing & human health18 16 
Total Revenue$1,986 $1,871